Specialty Pharmacy Network

Indy Health Insurance Company Seeking Investor Partners | PR Newswire | 7/22/2020

… move from surviving the current U.S. drug pricing crisis to thriving,” said Ms. Atkinson. In addition, Indy Health Independent Preferred Network members will have better reimbursements, no restrictions to mail and an independent Preferred Specialty Pharmacy Network . Through Indy Health Insurance Company, Medicare-D plan independent pharmacies will ultimately be able to create their own formulary, medication therapy management services and negotiate their own rebates through an independently owned, sustainable …

The specialty pharmacy divide: How health systems and payers can find common ground | Becker’s Hospital Review | 7/8/2020

… enter more risk-based contracts with payers. However, when it comes to establishing a specialty pharmacy service, they often face challenges related to accreditation, regulatory changes, and access to limited distribution drugs and payer specialty pharmacy network s, Dr. Buller said. Health systems see payers as being driven solely by the bottom line, willing to sacrifice care quality for cost. While cost is a primary decision-maker for payers, providers don’t …

Follow Specialty Pharmacy Network:    

Kyle Skiermont to join Prime Therapeutics as senior vice president, specialty pharmacy and home delivery services | PR Newswire | 4/23/2020

… role. He will lead Prime’s future strategy for specialty pharmacy and home delivery services. Skiermont will have responsibility for all aspects of the specialty pharmacy delivery channel including specialty product and clinical program development, specialty pharmacy network s and a specialty drug management model. He will bring his rich clinical experience and focus on patient experience to shape a specialty delivery approach designed to improve member quality, experience and value. His …

scPharmaceuticals Inc. Reports Fourth Quarter and Year Ended 2019 Financial Results and Provides Business Update | Financial Buzz | 3/24/2020

… FUROSCIX near completion, the Company has begun to turn attention to pre-commercialization efforts. The Company will be focused on specific pre-commercialization activities including establishing a managed care advisory board, contracting with a specialty pharmacy network , and conducting market research to prepare FUROSCIX product messaging and positioning. These pre-commercialization activities will be staged as appropriate to efficiently follow FUROSCIX’s regulatory progress. As part of these efforts, the Company …

ACR Advocates Against Payer Mandates on Specialty Pharmacy Acquisition of In-Office Treatments | 3/23/2020

Scientist Development Award Winner Probes Ethnic Disparities in Lupus Blue Cross Blue Shield of Tennessee (BCBST) announced in fall 2019 that all specialty drugs would have to be acquired through the BCBST specialty pharmacy network as of Jan. 1, 2020. After hearing significant opposition from stakeholders, it pushed back the implementation date to July 1, 2020. If BCBST moves forward with this policy, the ACR is concerned that other payers …

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network | Globe Newswire | 3/13/2020

JACKSONVILLE, FL, March 13, 2020 (GLOBE NEWSWIRE) – via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical Home Pharmacy ( http://www.medicalhomepharmacy.com/ , https://www.youtube.com/watch?v=LWqRacr …

mCig, Inc. (MCIG) Signs Letter of Intent | Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™ | 3/13/2020

mCig Inc. Signs Letter of Intent With Multi-State Licensed PCAB Accredited Compounding, Retail, and Specialty Pharmacy Network mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced execution of a Letter of Intent (LOI) reflecting the Company’s strategic partnership with NJ based, Kaplan Group d/b/a Medical …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | Physicians Weekly | 1/10/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | News | WIN 98.5 | 1/9/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | News | MIX-FM | 1/9/2020

… the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network in the United States within a week, with a wholesale acquisition cost or list price of $32,000 for a 30-day supply, regardless of dosage. The list price is not necessarily what patients …

Albertsons Joins AssistRx Specialty Pharmacy Network | 12/19/2019

Albertsons Joins AssistRx Specialty Pharmacy Network Press enter to search Subscribe AssistRx’s integrated access solution, iAssist, was developed to simplify the process and delivery of prescriptions to the pharmacy Albertsons Cos. Specialty Care is now using the AssistRx technology platform to give patients and providers faster access to specialty prescription medications and support services. Via AssistRx’s integrated access solution, iAssist, patient prescription information is captured electronically by Albertsons Specialty Care …

Trellis Rx Helps Patients Secure More Than $13.5 Million in Financial Assistance for Specialty Medications in First Ten Months Of 2019 | Business Wire | 12/3/2019

… Rx has also fostered a number of partnerships with nationally recognized payors and pharmaceutical companies on behalf of its health system partners. For example, Trellis Rx helped North Memorial Health gain access to the specialty pharmacy network of its largest commercial payor. Trellis Rx is also partnering with pharmaceutical manufacturers and North Memorial Health providers on clinical outcomes studies in oncology and rheumatology. In addition to fostering relationships with health …

Account Manager - Managed Care - Minneapolis - Minneapolis, MN, , USA #jobs #Minneapolis pls RT | 11/23/2019

Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network , Minneapolis, MN, , USA Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network , Minneapolis, MN, , USA Jobs In Account Manager Managed Care … Jobs In Account Manage… Jobs In Account M… Position Summary:The Account Manager Managed Care is a corporate-based position responsible for overseeing payer …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

Diplomat Announces 3rd Quarter Financial Results; Updates 2019 Guidance | PR Newswire | 11/12/2019

… business, including the ongoing pressures on our PBM business. In addition, we are disappointed we were unable to come to an agreement with one of our large payers to renew network participation in their specialty pharmacy network . We continue to pursue a comprehensive strategic alternatives process. There has been interest in both the whole company and its businesses, and we are engaged in advanced discussions. At the same time, we …

Diplomat posts Q3 loss along with drop in PBM segment | 11/12/2019

… business, including the ongoing pressures on our PBM business. In addition, we are disappointed we were unable to come to an agreement with one of our large payers to renew network participation in their specialty pharmacy network . We continue to pursue a comprehensive strategic alternatives process. There has been interest in both the whole company and its businesses, and we are engaged in advanced discussions. At the same time, we …

Premier Pharmacy Services Distributing Gammacore Through A Limited Specialty Pharmacy Network Selected By Electrocore, Inc. | 9/26/2019

Premier Pharmacy Services can supply patients access to this device for the treatment of cluster headaches and migraine headaches. Baldwin Park, CA - September 25, 2019 /MarketersMedia/ — Since July 2017, Premier Pharmacy Services has been part of a group of specialty pharmacies selected by electroCore, Inc. to dispense a non-invasive vagus nerve stimulator known as GAMMACORE. GAMMACORE is used to relieve symptoms of cluster and migraine headaches in adult patients …

Supervisor - Specialty Pharmacy Services - USA-HI-Honolulu | 9/16/2019

Job DescriptionJob DescriptionAs a Supervisor of Specialty Pharmacy Services, you are responsible for the direct daily supervision of Pharmacy Service Representatives (PSRs) providing proactive compliance and ordering calls for all medications dispensed by CVS Specialty Pharmacy Network . Critical responsibilities include participation in the recruiting and hiring process, provision of guidance and direction to staff, schedule preparation and management, ensuring adherence to standard operating procedures, staff training, problem solving and follow …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | 8/6/2019

… complex patients. Excelera will partner with HonorHealth to develop key specialty pharmacy capabilities including training, operations, data aggregation, reporting for drug manufacturers and payers, revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment to caring for complex pharmacy patients. ExceleraRx Corp. is a healthcare …

Excelera® Specialty Pharmacy Network Welcomes H… ( MINNEAP…) | 8/6/2019

… complex patients. Excelera will partner with HonorHealth to develop key specialty pharmacy capabilities including training, operations, data aggregation, reporting for drug manufacturers and payers, revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment to caring for complex pharmacy patients. ExceleraRx Corp. is a healthcare …

Onco360® Selected to Dispense Nubeqa® (darolutamide) | Business Wire | 8/2/2019

LOUISVILLE, Ky.–(BUSINESS WIRE)–Aug 2, 2019– Onco360 ®, the nation’s largest independent Oncology Pharmacy, announced today that it was selected to be a specialty pharmacy network partner for Karyopharm’s new product Nubeqa® (darolutamide) for the treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC). “Onco360 is honored to be selected as a specialty pharmacy provider for Nubeqa® patients,” said Paul Jardina, President and CEO, Onco360. “The recent approval …

Premier Pharmacy Services Distributing Samsca(R) Through a Limited Specialty Pharmacy Network Selected by Otsuka America Pharmaceuticals Inc. | 7/27/2019

Premier Pharmacy Services can Supply Patients Access to this Aquaretic for the Treatment of Hyponatremia BALDWIN PARK, CA / ACCESSWIRE / July 26, 2019 / Since 2015 , Premier Pharmacy Services has been part of a pharmacy network , designed by Otsuka America Pharmaceutical, Inc. (Otsuka) to distribute SAMSCA ® (tolvaptan). This medication is used to treat patients diagnosed with hyponatremia - a condition characterized by excessively low sodium levels in the blood. Premier Pharmacy Services is …

Top 3 Reasons To Pick Up GW Pharmaceuticals In July 2019 - GW Pharmaceuticals plc (NASDAQ:GWPH) | Seeking Alpha | 7/9/2019

… end of the fourth quarter to two weeks at the end of the first quarter, thereby removing a major challenge to the uptake of the drug. To overcome this problem, GW Pharmaceuticals expanded its specialty pharmacy network from five to over 140 by adding specialty pharmacies that exist within the larger academic clinics. GW Pharmaceuticals has also managed to secure access to around 90% of all lives covered by commercial …

Onco360® Selected to Dispense XPOVIO™ (selinexor) | Business Wire | 7/3/2019

LOUISVILLE, Ky.–(BUSINESS WIRE)–Jul 3, 2019– Onco360 ®, the nation’s largest independent Oncology Pharmacy, announced today that it was selected to be a specialty pharmacy network partner for Karyopharm’s new product XPOVIO ™ (selinexor) a nuclear export inhibitor indicated in combination with dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least four prior therapies and whose disease is refractory to at …

Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation | PRWeb | 6/25/2019

Excelera Member Pharmacists Earn Exclusive “Certified Specialty Pharmacist” Accreditation Share Article Specialty pharmacists within the Excelera Specialty Pharmacy Network continue to demonstrate strong commitment to high-caliber expertise in specialty pharmacy “This accreditation is a noteworthy achievement and we applaud our Members’ dedication to high-quality care,” said Lorrie Carr, CEO of ExceleraRx Corp. MINNEAPOLIS ExceleraRx® Corp is pleased to recognize member pharmacists who have earned or recertified for the …

Food and Drug Administration

FDA approves Blueprint’s stomach cancer therapy priced at $32,000 per month | Physicians Weekly | 1/10/2020

Food and Drug Administration approved Blueprint Medicines Corp’s oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday. The FDA’s decision makes the therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of the cancer called gastrointestinal stromal tumor (GIST). Blueprint said it expects to make Ayvakit available through a limited specialty pharmacy network

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Business Wire | 11/21/2019

… BUSINESS WIRE)–Nov 21, 2019– Onco360 ®, the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with … research-based biotechnology company, and was approved by the U.S. Food and Drug Administration (FDA) to treat adult patients with MCL on November 14, 2019. The FDA’s approval of BRUKINSA is based on efficacy results …

Coordinated Care

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system … implement and optimize their specialty pharmacies to provide patients with coordinated care and increased access to limited distribution drugs (LLDs). With the membership of HonorHealth, Excelera now boasts a combined network specialty pharmacy revenue of …

Excelera Promotes Troy Polan to Chief Technology Officer | PRWeb | 4/16/2019

… validation and standardization of health data. “Excelera uses its robust data platform to provide key insights demonstrating the value of coordinated care for complex patients,” said Polan. “It will be increasingly important to delve even … time, he has helped to establish and grow the Excelera Specialty Pharmacy Network, which is comprised of integrated delivery networks, health systems and large academic medical centers with a deep commitment to caring for complex …

ExceleraRx

Account Manager - Managed Care - Minneapolis - Minneapolis, MN, , USA #jobs #Minneapolis pls RT | 11/23/2019

Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network, Minneapolis, MN, , USA Job Detail for Account Manager - Managed Care - Minneapolis Job Location: ExceleraRx Corp - A National Specialty Pharmacy Network, Minneapolis, MN, , USA Jobs In Account Manager Managed Care … Jobs In Account Manage… Jobs In Account M… Position Summary:The Account Manager Managed Care is a corporate-based position responsible for overseeing payer …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

BeiGene

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | BioSpace | 11/21/2019

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 Published: Nov 21, 2019 LOUISVILLE, Ky.–( BUSINESS WIRE )– Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second …

Excelera

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | 8/6/2019

MINNEAPOLIS (PRWEB) August 06, 2019 The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic medical center specialty pharmacies. The Excelera Network has … revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

HonorHealth

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | 8/6/2019

MINNEAPOLIS (PRWEB) August 06, 2019 The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic medical center specialty pharmacies. The Excelera Network has … revenue cycle management, and pharmacy business office. About The Excelera® Specialty Pharmacy Network The Excelera® Specialty Pharmacy Network is comprised of integrated delivery networks, health systems, and large academic medical centers with a deep commitment …

Excelera® Specialty Pharmacy Network Welcomes HonorHealth | PRWeb | 8/6/2019

Excelera® Specialty Pharmacy Network Welcomes HonorHealth Share Article Second Arizona-based member to join the network, serving Scottsdale and Phoenix “We are pleased to add HonorHealth to our growing network of high-quality health system members,” said Brady Atherton, VP Sales and Business Development of ExceleraRx Corp. MINNEAPOLIS The ExceleraRx Corporation is proud to announce that HonorHealth has joined the Excelera Network, a nationwide network of health systems and academic …

Paul Jardina

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | Malvern Daily Record | 11/21/2019

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul …

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360 | BioSpace | 11/21/2019

specialty pharmacy network partner for BRUKINSA ™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients with relapsed and refractory MCL is an important advancement in fighting this devastating disease,” said Paul Jardina, President and CEO, Onco360. “As a specialty pharmacy dedicated to serving people with cancer …